Avecia - Crunchbase Company Profile & Funding

Q: Where is Avecia's headquarters?

Avecia is located in Milford, Massachusetts, United States.

Overview

Avecia

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Avecia

CB Rank

329772

Avecia is a biotechnology company focused on the development and manufacture of innovative biotechnology-based medicines.

Acquired by

Nitto Denko

Founded

obfuscation

Private

Milford, Massachusetts, United States

501-1000

www.avecia.com

Biotechnology

Manufacturing

Pharmaceutical

Key People

James O'Donnell: Principal Scientist
James O'Donnell: Sr. Process Development Chemist

Details

Operating Status

Active

Company Type

For Profit

About the Company

Avecia is a leading private biotechnology company, operating through its OligoMedicines business, focused on the development and manufacture of innovative biotechnology-based medicines. With a long history of technological innovation, they work closely with their customers who are typically biotechnology or pharmaceutical companies, helping them

achieve fast progress into, and through, the clinical development programme.

Phone Number

5085322503

Contact Email

oligrow@avecia.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

OliGrow® Preclinical Manufacturing

Custom oligonucleotide synthesis and manufacturing service for preclinical research, producing batch sizes from 100 mg to 25 g with various chemistries and sequence types.

Analytical Development

Development, qualification, and validation of analytical methods for oligonucleotide raw materials, intermediates, and final products to support drug development phases.